Viewing Study NCT03518606

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 1:16 PM
Ignite Modification Date: 2026-02-03 @ 5:19 AM
Study NCT ID: NCT03518606
Status: COMPLETED
Last Update Posted: 2025-01-15
First Post: 2018-04-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours
Sponsor: UNICANCER
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumours View
None Breast Cancer View
None Head and Neck Cancer View
None Cervix Cancer View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced solid tumours View
None Durvalumab View
None Tremelimumab View
None Metronomic vinorelbine View
None High mutational load malignancies View
None Immunotherapy View
None Early phase View
None Combination study View